bromodeoxyuridine has been researched along with Abnormalities, Cardiovascular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Z | 1 |
| Bader, DM; Dees, E; Galindo, CL; Hunt, RP; Miller, PM; Moynihan, KL; Pooley, RD; Rottman, JN | 1 |
| Bolender, DL; Franciosi, JP; Kolesari, GL; Lough, J | 1 |
3 other study(ies) available for bromodeoxyuridine and Abnormalities, Cardiovascular
| Article | Year |
|---|---|
Activin-A in diabetes-induced cardiac malformations in embryos.
Topics: Animals; Bromodeoxyuridine; Cardiovascular Abnormalities; Cell Movement; Cell Proliferation; Endocardium; Female; Immunohistochemistry; Inhibin-beta Subunits; Mice; Mice, Inbred C57BL; Myocardium; Phosphorylation; Pregnancy; Pregnancy in Diabetics; Smad3 Protein | 2013 |
Cardiac-specific deletion of the microtubule-binding protein CENP-F causes dilated cardiomyopathy.
Topics: Aging; Animals; Animals, Newborn; Bromodeoxyuridine; Cardiomyopathy, Dilated; Cardiovascular Abnormalities; Cell Proliferation; Chromosomal Proteins, Non-Histone; Costameres; Fibrosis; Gene Deletion; Gene Expression Profiling; Heart; Integrases; Mice; Mice, Knockout; Microfilament Proteins; Microtubules; Myocytes, Cardiac; Organ Specificity; Protein Binding; Transcription, Genetic; Troponin T | 2012 |
FGF-2-induced imbalance in early embryonic heart cell proliferation: a potential cause of late cardiovascular anomalies.
Topics: Abnormalities, Drug-Induced; Animals; Bromodeoxyuridine; Cardiovascular Abnormalities; Cell Count; Cell Division; Chick Embryo; Fibroblast Growth Factor 2; Fluorescent Antibody Technique, Indirect; Heart; Myocardium | 2000 |